Julia Lainster

Julia Lainster

HealthTech Solutions Expert
Julia Lainster is an expert in Healthtech with a focus on electronic health records, interoperability standards, and cybersecurity. Her content is geared toward industry leaders and organizations seeking to leverage technology to improve efficiency, accuracy, and security in healthcare delivery. Julia aims to drive digital transformation and innovation in Healthtech.
NICE Approves Neuraxpharm's Ublituximab for RRMS Treatment in the UK
Research & Development NICE Approves Neuraxpharm's Ublituximab for RRMS Treatment in the UK

The recent endorsement of Neuraxpharm's ublituximab (BRIUMVI®) by the National Institute for Health and Care Excellence (NICE) marks a significant step forward in the treatment of relapsing-remitting multiple sclerosis (RRMS). This approval is a notable accomplishment for the European specialty

Study Links Ultra-Processed Foods to Increased Risk of Colorectal Cancer
Research & Development Study Links Ultra-Processed Foods to Increased Risk of Colorectal Cancer

A recent study spearheaded by University of South Florida (USF) Health researchers, in collaboration with TGH Cancer Institute, has unveiled a potential link between ultra-processed foods and an increased risk of colorectal cancer. Researchers highlighted how these foods may contribute to chronic

Public Demand for Transparent AI Use Notification in Healthcare
Tech & Innovation Public Demand for Transparent AI Use Notification in Healthcare

The integration of artificial intelligence (AI) in healthcare is rapidly advancing, promising significant improvements in patient care and operational efficiency. Nonetheless, as this technological leap transforms medical practices, it also raises critical ethical considerations, particularly

How Are Portable MRIs and AI Transforming Alzheimer's Diagnosis?
Tech & Innovation How Are Portable MRIs and AI Transforming Alzheimer's Diagnosis?

Alzheimer’s disease (AD) is a progressive neurodegenerative condition that significantly impacts memory, cognition, and behavior. Early detection is crucial for effective intervention, especially with the development of new anti-amyloid therapies. However, traditional diagnostic tools face

Can Immunotherapy Before and After Surgery Improve NSCLC Outcomes?
Research & Development Can Immunotherapy Before and After Surgery Improve NSCLC Outcomes?

The PROSPECT-Lung trial has officially commenced, heralding a significant advance in the quest to enhance treatment strategies for patients with resectable non-small cell lung cancer (NSCLC). This trial marks the inaugural endeavor of the newly established National Cancer Institute (NCI) Clinical

How Does NK Cell Dysfunction Worsen Severe RSV in Children?
Research & Development How Does NK Cell Dysfunction Worsen Severe RSV in Children?

Respiratory Syncytial Virus (RSV) is a common virus that infects nearly all children by the age of two, but while most cases are mild, some children experience severe respiratory illness that requires hospitalization. The mechanisms behind this severity, especially the role and dysfunction of

Can Bovine H5N1 Mutations Lead to Human Adaptation and Transmission?
Research & Development Can Bovine H5N1 Mutations Lead to Human Adaptation and Transmission?

The emergence of highly pathogenic avian influenza (HPAI) H5N1 in 1996 marked a significant event in the history of infectious diseases. Over the years, this virus has spread across continents, infecting various species and creating diverse clades. The potential for H5N1 to adapt to humans through

Advancements and Challenges in Drug Addiction Treatment Strategies
Research & Development Advancements and Challenges in Drug Addiction Treatment Strategies

Drug addiction has been a persistent issue throughout human history, documented from ancient times. Traditionally viewed as a moral failing rather than a treatable disease, the perception of addiction began to shift in the 20th century with scientific discoveries highlighting its basis in brain

Innovative Cell-Based Immunotherapy Reduces Tumors in Breast Cancer Trial
Research & Development Innovative Cell-Based Immunotherapy Reduces Tumors in Breast Cancer Trial

In a remarkable breakthrough in breast cancer treatment, a novel cell-based immunotherapy developed by Dr. Gary Koski from Kent State University and Dr. Brian J. Czerniecki from the Moffitt Cancer Center has been recently accepted for publication in JAMA Oncology. This innovative approach harnesses

How Will FDA's New Guidance Change AI/ML Medical Device Regulation?
Tech & Innovation How Will FDA's New Guidance Change AI/ML Medical Device Regulation?

Earlier this week, the U.S. Food and Drug Administration (FDA) unveiled its much-anticipated final guidance on predetermined change control plans (PCCPs) for devices incorporating artificial intelligence and machine learning (AI/ML) software. This guidance signifies a significant milestone in the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later